- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02889146
Progressive Mobility Program and Technology to Improve the Level of Physical Activity and Functionality of ICU Patients
November 28, 2018 updated by: University of Sao Paulo General Hospital
Using a Progressive Mobility Program and Technology to Increase the Level of Physical Activity and Its Benefits in Respiratory, Muscular System and Functionality of ICU Patients: a Randomized Clinical Trial
The purpose of this study is to verify if a protocol of early and progressive mobility which includes the use of technology is able to increase the level of physical activity and improve functionality and respiratory and muscular function of Intensive Care Unit patients compared with conventional Physical Therapy.
Study Overview
Status
Completed
Conditions
Detailed Description
The evolution of treatment in the Intensive Care Unit (ICU) has increased the survival and morbidity post hospital.
Functional disability in these patients has its main factor in the weakness and loss of muscle mass, which is the major complications reported by these patients.
The most negative result in long-term post ICU is the impact on quality of life and functional decline due to muscle disorders and fitness.
This is achieved by the period of inactivity and prolonged rest, leading to losses and changes in various body systems.
Given these facts, interventions for greater mobility in bed and out of it are very important.
Early mobility programs has proved beneficial, however, as in other types of rehabilitation, the exercises should be prescribed with its specific characteristics, including the intensity.
However, little has been described in the researches abut the activity level in the ICU, and using a quantitative measure.
The use of technology seems to facilitate the offering of this type of therapy, supplying the limitations.
Therefore, there are little evidences about these topics and randomized controlled studies to investigate these factors.
Study Type
Interventional
Enrollment (Actual)
98
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
SP
-
Sao Paulo, SP, Brazil, 05360-000
- Department of Physiotherapy, Communication Science & Disorders, Occupational Therapy - Medical School of University of Sao Paulo
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- admitted to the Emergency Intensive Care Unit of Clinical Hospital, Medical School, University os Sao Paulo
- inspired oxygen fraction ≤ 60%
- positive end expiratory pressure ≤ 10 points
- peripheral oxygen saturation ≥ 90%
- respiratory rate ≤ 35
- without cardiac arrhythmia or acute ischaemia
- heart rate > 50 bpm and < 140 bpm
- without high or raising dose of vasoactive drugs
- mean body pressure > 60 mmHg and < 120 mmHg
- without active bleeding
- without prescribed bedrest
Exclusion Criteria:
- transference from other hospital
- diagnosis of neurological disorders
- intensive care unit stay < 4 days
- contraindication to mobilization
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Control group
Conventional Physical Therapy: motor physical therapy delivered by the intensive care unit physical therapists, according to his own criteria, without following any protocol.
Respiratory therapy.
|
Control group will receive respiratory therapy according to the service routine and conventional physical therapy.
Conventional physical therapy will be offered by the hospital physical therapists, according to their own criteria.
Consists of passive, assisted and resisted mobilization, positioning in bed, transferring to bedside or chair, orthostatism and deambulation, however without a definition of a protocol.
The physical therapist will be responsible for the choice of the techniques employed in each session.
There will be no previous definition of the next sessions.
No technology equipment will be used in this group, since they are not available in the routine care.
Respiratory therapy according to the service routine.
|
|
Experimental: Protocol group
Early and progressive mobilization program: motor physical therapy delivered by a trained physical therapist according to the mobilization protocol, in which patient progress according to his performance.
Respiratory therapy.
|
Respiratory therapy according to the service routine.
Protocol group will receive respiratory therapy according to the service routine and motor physical therapy according to the program of early and progressive mobilization.
Patients will receive the program once daily during the intensive care unit stay, offered by a trained physical therapist, at the adequate level according to the level of consciousness and muscle strength.
The program contains by techniques for muscle length and muscle strength maintenance or gain, aerobic exercises, exercises for gait rehabilitation and cognitive components.
Patient will progress to the next level of the protocol completing the previous level.
Technology equipment available: functional electrical stimulation device, dumbbells, cycle ergometer, fixed walker, ambulation assistive device and video game.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Functional status
Time Frame: At the time of discharge from the ICU, at least 4 days after admission.
|
Ability to perform daily living activities assessed by Barthel Index
|
At the time of discharge from the ICU, at least 4 days after admission.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Level of physical activity during the whole intensive care unit stay
Time Frame: At the time of discharge from the ICU, at least 4 days after admission.
|
Level of physical activity measured by an accelerometer
|
At the time of discharge from the ICU, at least 4 days after admission.
|
|
Pulmonary function
Time Frame: At the time of discharge from the ICU, at least 4 days after admission.
|
Pulmonary function assessed by a spirometer
|
At the time of discharge from the ICU, at least 4 days after admission.
|
|
Maximum inspiratory pressure
Time Frame: At the time of discharge from the ICU, at least 4 days after admission.
|
Maximum inspiratory pressure measured by an specific equipment
|
At the time of discharge from the ICU, at least 4 days after admission.
|
|
Peripheral muscle strength
Time Frame: At the time of discharge from the ICU, at least 4 days after admission.
|
Muscle strength assessed by hand grip dynamometer
|
At the time of discharge from the ICU, at least 4 days after admission.
|
|
Electromyography muscle activity
Time Frame: At the time of discharge from the ICU, at least 4 days after admission.
|
Quadriceps femoris electric activity assessed by surface electromyography
|
At the time of discharge from the ICU, at least 4 days after admission.
|
|
Muscle function and mobility
Time Frame: At the time of discharge from the ICU, at least 4 days after admission.
|
Test by Time up and Go
|
At the time of discharge from the ICU, at least 4 days after admission.
|
|
Intensive care unit length of stay
Time Frame: At the time of discharge from the ICU, at least 4 days after admission.
|
Count of the number of days spent at the intensive care unit
|
At the time of discharge from the ICU, at least 4 days after admission.
|
|
Correlation between physiological variables and the level of physical activity
Time Frame: At the time of discharge from the ICU, at least 4 days after admission.
|
Correlation between the physiological variables collected during the study and the level of physical activity measured by the accelerometer
|
At the time of discharge from the ICU, at least 4 days after admission.
|
|
ICU mobility Scale
Time Frame: Through study completion, an average of 2 weeks
|
Measure of mobility milestones in critically ill patients.
|
Through study completion, an average of 2 weeks
|
|
Long term follow up
Time Frame: After three months and one year of discharge
|
Longer-term follow-up for functional status by Barthel Index after three months and one year of discharge
|
After three months and one year of discharge
|
|
Level of activity by Perceived Exertion
Time Frame: approximately 40 minutes after therapy, immediately after the end of the protocol
|
Level of exercise by Perceived Exertion by Borg Rating of Perceived Exertion Scale
|
approximately 40 minutes after therapy, immediately after the end of the protocol
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Carolina Fu, PhD, Department of Physiotherapy, Communication Science & Disorders, Occupational Therapy - Medical School of University of Sao Paulo
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Gomes TT, Schujmann DS, Fu C. Rehabilitation through virtual reality: physical activity of patients admitted to the intensive care unit. Rev Bras Ter Intensiva. 2019 Oct-Dec;31(4):456-463. doi: 10.5935/0103-507X.20190078.
- Schujmann DS, Lunardi AC, Fu C. Progressive mobility program and technology to increase the level of physical activity and its benefits in respiratory, muscular system, and functionality of ICU patients: study protocol for a randomized controlled trial. Trials. 2018 May 10;19(1):274. doi: 10.1186/s13063-018-2641-4.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 1, 2017
Primary Completion (Actual)
November 28, 2018
Study Completion (Actual)
November 28, 2018
Study Registration Dates
First Submitted
March 3, 2016
First Submitted That Met QC Criteria
August 30, 2016
First Posted (Estimate)
September 5, 2016
Study Record Updates
Last Update Posted (Actual)
November 29, 2018
Last Update Submitted That Met QC Criteria
November 28, 2018
Last Verified
November 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- deborass
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Critical Illness
-
Duke UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...Not yet recruitingDecision Making | Neonatal Critical Illness | Pediatric Critical IllnessUnited States
-
Duke UniversityNational Institute of Neurological Disorders and Stroke (NINDS); National Institutes...CompletedNeonatal Critical Illness | Pediatric Critical IllnessUnited States
-
Istituto Clinico HumanitasRecruitingCritical Illness Myopathy | Critical Illness Polyneuropathy | Critical Illness PolyneuromyopathyItaly
-
Yale UniversityNational Institute on Aging (NIA)RecruitingCritical Illness | Illness, CriticalUnited States
-
Assistance Publique - Hôpitaux de ParisEuropean Society of Intensive Care Medicine; French Society for Intensive Care and other collaboratorsRecruitingCritical Illness | Intensive Care Patients | Critical Illness Requiring Intensive Care - Sepsis | Critical Illness Requiring Intensive Care - Acute Brain Injury | Critical Illness Requiring Intensive Care - Major Surgery | Critical Illness Requiring Intensive Care - PolytraumaFrance
-
Boston Children's HospitalCompleted
-
McMaster UniversityLondon Health Sciences Centre; McMaster Children's Hospital; Canadian Critical...CompletedPediatric Critical IllnessCanada
-
Karolinska InstitutetNot yet recruitingPediatric Critical IllnessSweden
-
Istanbul Medeniyet UniversityRecruiting
-
Sándor BeniczkyUniversity of Aarhus; Danish Council for Independent Research; Søster og Verner...CompletedCritical Illness Myopathy | Myopathy Critical IllnessDenmark
Clinical Trials on Conventional Physical Therapy
-
Riphah International UniversityCompletedAdhesive Capsulitis of ShoulderPakistan
-
Riphah International UniversityNot yet recruitingCervical RadiculopathyPakistan
-
Federal University of BahiaFundação de Amparo à Pesquisa do Estado da BahiaUnknown
-
University of LahoreCompletedCerebral Palsy (CP) | Quadriplegic Cerebral PalsyPakistan
-
University of LahoreCompletedParkinson Disease | Neuro-Degenerative DiseasePakistan
-
Universidad Catolica Silva HenriquezAgencia Nacional de Investigacion y Desarrollo, ANIDActive, not recruiting
-
University of ValenciaCompleted
-
Kars State HospitalCompletedShoulder Pain | Myofascial Pain | HemiplegiaTurkey
-
University of LahoreCompletedDiabetic NeuropathiesPakistan
-
University of LahoreCompletedLow Back Pain, MechanicalPakistan